News FDA OKs First Drug for Geographic Atrophy, a Major Cause of Adult Blindness by Medscape • 2023/02/17 • 0 Comments "The approval of SYFOVRE is the most important event in retinal ophthalmology in more than a decade." FDA Approvals Full Story →